Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 21, 2015

Study Completion Date

May 21, 2015

Conditions
Advanced Colorectal AdenomasAdenocarcinoma of the ColonStage I Colon CancerStage II Colon CancerStage III Colon Cancer
Interventions
DRUG

defined green tea catechin extract

Given PO

OTHER

placebo

Given PO

OTHER

questionnaire administration

Ancillary studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (3)

55905

Mayo Clinic, Rochester

60612

University of Illinois, Chicago

Hines Veteran's Administration Hospital, Hines

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER